尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Barbari Sharon, 董事. Director active across 1 company, notably Agile Therapeutics INC. Cumulatively, 4 filings have been published. Activity tracked since 8 June 2021. The latest transaction was disclosed on 26 August 2024 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Sharon Barbarie is a Board Member at Agile Therapeutics Inc. She brings expertise in corporate strategy and product development. Her role on the board is crucial in guiding strategic decisions and ensuring that Agile Therapeutics continues to grow and innovate.